Concepedia

Anna Kruschinski

AK

Statistics

Publications

13

Citations

993

H-Index

11

Active since

2008

Affiliations

Noxxon Pharma (Germany)(Current)

Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda

Universitair Ziekenhuis Leuven

Sapienza University of Rome

Innsbruck Medical University

Anna Kruschinski is an author at Noxxon Pharma (Germany) specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

2008–2017

13

Publications

13

The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization

Julia Hoellenriegel, Dirk Zboralski, Christian Maasch et al. · Blood · 2013 · 229 citations · Full text

Engineering antigen-specific primary human NK cells against HER-2 positive carcinomas

Anna Kruschinski, Andreas Moosmann, Isabel Poschke et al. · Proceedings of the National Academy of Sciences · 2008 · 193 citations · Full text

, , +16

SDF-1 Inhibition Targets the Bone Marrow Niche for Cancer Therapy

Aldo M. Roccaro, Antonio Sacco, Werner G. Purschke et al. · Cell Reports · 2014 · 135 citations · Full text

Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats

Shie-Chau Liu, Reem Alomran, Sophia B. Chernikova et al. · Neuro-Oncology · 2013 · 91 citations · Full text

Hematopoietic Stem and Progenitor Cell Mobilization in Mice and Humans by a First-in-Class Mirror-Image Oligonucleotide Inhibitor of CXCL12

Axel Vater, Jörg Sahlmann, Nicolaus Kröger et al. · Clinical Pharmacology & Therapeutics · 2013 · 85 citations · Full text

1–5 of 13